Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback